Unknown

Dataset Information

0

Discovery of novel 2-aryl-4-benzoyl-imidazole (ABI-III) analogues targeting tubulin polymerization as antiproliferative agents.


ABSTRACT: Novel ABI-III compounds were designed and synthesized based on our previously reported ABI-I and ABI-II analogues. ABI-III compounds are highly potent against a panel of melanoma and prostate cancer cell lines, with the best compound having an average IC(50) value of 3.8 nM. They are not substrate of Pgp and thus may effectively overcome Pgp-mediated multidrug resistance. ABI-III analogues maintain their mechanisms of action by inhibition of tubulin polymerization.

SUBMITTER: Chen J 

PROVIDER: S-EPMC3426659 | biostudies-literature | 2012 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Discovery of novel 2-aryl-4-benzoyl-imidazole (ABI-III) analogues targeting tubulin polymerization as antiproliferative agents.

Chen Jianjun J   Ahn Sunjoo S   Wang Jin J   Lu Yan Y   Dalton James T JT   Miller Duane D DD   Li Wei W  

Journal of medicinal chemistry 20120806 16


Novel ABI-III compounds were designed and synthesized based on our previously reported ABI-I and ABI-II analogues. ABI-III compounds are highly potent against a panel of melanoma and prostate cancer cell lines, with the best compound having an average IC(50) value of 3.8 nM. They are not substrate of Pgp and thus may effectively overcome Pgp-mediated multidrug resistance. ABI-III analogues maintain their mechanisms of action by inhibition of tubulin polymerization. ...[more]

Similar Datasets

| S-EPMC4416488 | biostudies-literature
| S-EPMC7866144 | biostudies-literature
| S-EPMC3599526 | biostudies-literature
| S-EPMC4554882 | biostudies-literature